Literature DB >> 17018525

The NH2-terminal propeptide of type I procollagen acts intracellularly to modulate cell function.

Anush Oganesian1, Sandra Au, Jeremy A Horst, Lars C Holzhausen, Athena J Macy, James M Pace, Paul Bornstein.   

Abstract

The function of the NH(2)-terminal propeptide of type I procollagen (N-propeptide) is poorly understood. We now show that a recombinant trimeric N-propeptide interacts with transforming growth factor-beta1 and BMP2 and exhibits functional effects in stably transfected cells. The synthesis of N-propeptide by COS-7 cells results in an increase in phosphorylation of Akt and Smad3 and is associated with a marked reduction in type I procollagen synthesis and impairment in adhesion. In C2C12 cells, N-propeptide inhibits the osteoblastic differentiation induced by BMP2. Our data suggest that these effects are mediated by the interaction of N-propeptide with an intracellular receptor in the secretory pathway, because they are not observed when recombinant N-propeptide is added to the culture medium of either COS-7 or C2C12 cells. Both the binding of N-propeptide to cytokines and its functional properties are entirely dependent on the exon 2-encoded globular domain, and a mutation that substitutes a serine for a highly conserved cysteine in exon 2 abolishes its function. Our findings suggest that N-propeptide performs an important feedback regulatory function and provides a rationale for the prominence of a homotrimeric form of type I procollagen (alpha1 trimer) during vertebrate development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17018525      PMCID: PMC3086210          DOI: 10.1074/jbc.M607536200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

Review 1.  Procollagen.

Authors:  G R Martin; P H Byers; K A Piez
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1975

2.  Collagen synthesis by human amniotic fluid cells in culture: characterization of a procollagen with three identical proalpha1(I) chains.

Authors:  E Crouch; P Bornstein
Journal:  Biochemistry       Date:  1978-12-12       Impact factor: 3.162

Review 3.  Dual role for TGF-beta1 in apoptosis.

Authors:  Amelia Sánchez-Capelo
Journal:  Cytokine Growth Factor Rev       Date:  2005-01-25       Impact factor: 7.638

4.  Physical properties of the amino-terminal precursor-specific portion of type I procollagen.

Authors:  J Engel; P Bruckner; U Becker; R Timpl; B Rutschmann
Journal:  Biochemistry       Date:  1977-09-06       Impact factor: 3.162

5.  Inhibiting effect of procollagen peptides on collagen biosynthesis in fibroblast cultures.

Authors:  M Wiestner; T Krieg; D Hörlein; R W Glanville; P Fietzek; P K Müller
Journal:  J Biol Chem       Date:  1979-08-10       Impact factor: 5.157

Review 6.  The biosynthesis of collagen.

Authors:  P Bornstein
Journal:  Annu Rev Biochem       Date:  1974       Impact factor: 23.643

7.  Identification of collagen alpha1(I) trimer in embryonic chick tendons and calvaria.

Authors:  S A Jimenez; R I Bashey; M Benditt; R Yankowski
Journal:  Biochem Biophys Res Commun       Date:  1977-10-24       Impact factor: 3.575

8.  Three conformationally distinct domains in the amino-terminal segment of type III procollagen and its rapid triple helix leads to and comes from coil transition.

Authors:  P Bruckner; H P Bächinger; R Timpl; J Engel
Journal:  Eur J Biochem       Date:  1978-10-16

9.  Akt interacts directly with Smad3 to regulate the sensitivity to TGF-beta induced apoptosis.

Authors:  Andrew R Conery; Yanna Cao; E Aubrey Thompson; Courtney M Townsend; Tien C Ko; Kunxin Luo
Journal:  Nat Cell Biol       Date:  2004-04       Impact factor: 28.824

10.  The propeptide domain of lysyl oxidase induces phenotypic reversion of ras-transformed cells.

Authors:  Amitha H Palamakumbura; Sébastien Jeay; Ying Guo; Nicole Pischon; Pascal Sommer; Gail E Sonenshein; Philip C Trackman
Journal:  J Biol Chem       Date:  2004-07-23       Impact factor: 5.157

View more
  10 in total

1.  Type IIB procollagen NH(2)-propeptide induces death of tumor cells via interaction with integrins alpha(V)beta(3) and alpha(V)beta(5).

Authors:  Zhepeng Wang; Jennifer Bryan; Carl Franz; Necat Havlioglu; Linda J Sandell
Journal:  J Biol Chem       Date:  2010-05-03       Impact factor: 5.157

2.  Diminished type III collagen promotes myofibroblast differentiation and increases scar deposition in cutaneous wound healing.

Authors:  Susan W Volk; Yanjian Wang; Elizabeth A Mauldin; Kenneth W Liechty; Sherrill L Adams
Journal:  Cells Tissues Organs       Date:  2011-01-19       Impact factor: 2.481

3.  Expression in SPARC-null mice of collagen type I lacking the globular domain of the α1(I) N-propeptide results in abdominal hernias and loss of dermal collagen.

Authors:  Lauren Card; Nikki Henderson; Yuhua Zhang; Paul Bornstein; Amy D Bradshaw
Journal:  Matrix Biol       Date:  2010-08-11       Impact factor: 11.583

Review 4.  Lysyl oxidase: a potential target for cancer therapy.

Authors:  V M Berlin Grace; C Guruvayoorappan
Journal:  Inflammopharmacology       Date:  2010-11-24       Impact factor: 4.473

5.  Type III collagen regulates osteoblastogenesis and the quantity of trabecular bone.

Authors:  Susan W Volk; Shalin R Shah; Arthur J Cohen; Yanjian Wang; Becky K Brisson; Laurie K Vogel; Kurt D Hankenson; Sherrill L Adams
Journal:  Calcif Tissue Int       Date:  2014-03-14       Impact factor: 4.333

6.  Novel action of FOXL2 as mediator of Col1a2 gene autoregulation.

Authors:  Mara Marongiu; Manila Deiana; Loredana Marcia; Andrea Sbardellati; Isadora Asunis; Alessandra Meloni; Andrea Angius; Roberto Cusano; Angela Loi; Francesca Crobu; Giorgio Fotia; Francesco Cucca; David Schlessinger; Laura Crisponi
Journal:  Dev Biol       Date:  2016-05-19       Impact factor: 3.582

Review 7.  The rationale for targeting the LOX family in cancer.

Authors:  Holly E Barker; Thomas R Cox; Janine T Erler
Journal:  Nat Rev Cancer       Date:  2012-07-19       Impact factor: 60.716

8.  Giantin is required for intracellular N-terminal processing of type I procollagen.

Authors:  Nicola L Stevenson; Dylan J M Bergen; Yinhui Lu; M Esther Prada-Sanchez; Karl E Kadler; Chrissy L Hammond; David J Stephens
Journal:  J Cell Biol       Date:  2021-05-04       Impact factor: 10.539

9.  Cysteine-rich domain of type III collagen N-propeptide inhibits fibroblast activation by attenuating TGFβ signaling.

Authors:  Becky K Brisson; Daniel C Stewart; Chelsea Burgwin; David Chenoweth; Rebecca G Wells; Sherrill L Adams; Susan W Volk
Journal:  Matrix Biol       Date:  2022-03-24       Impact factor: 10.447

10.  Fortilin interacts with TGF-β1 and prevents TGF-β receptor activation.

Authors:  Decha Pinkaew; Erik Martinez-Hackert; Wei Jia; Matthew D King; Fei Miao; Nicole R Enger; Runglawan Silakit; Kota Ramana; Shi-You Chen; Ken Fujise
Journal:  Commun Biol       Date:  2022-02-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.